- Zoetis is introducing Vetscan OptiCell™ as it continues to transform diagnostics with its suite of integrated products and services
- The cartridge-based hematology analyzer offers innovative AI-powered technology for CBC analysis, providing reference lab quality accuracy1 at the point of care
- The analyzer represents significant time, cost and space savings for clinicians with minimal maintenance requirements
Zoetis Inc., the world’s leading animal health company, is set to unveil its new hematology analyzer Vetscan OptiCell™, a cartridge-based, AI-powered diagnostic tool that provides advanced Complete Blood Count (CBC) analysis. The analyzer – to be introduced to the U.S. market later this year – represents a significant leap in technology and offers meaningful time, cost and space savings for veterinary care teams, to enable better patient outcomes and allows for a more efficient clinic workflow.
Vetscan OptiCell reaffirms Zoetis’ longstanding commitment to advancing veterinary medicine through meaningful innovation. The latest addition to Zoetis’ suite of diagnostic products and services offers an advanced approach to hematology by utilizing cell-focusing and AI-powered classification technology for CBC analysis, delivering reference lab quality accuracy1 at the point of care.
Abhay Nayak, President of Global Diagnostics at Zoetis said, “This latest innovation further strengthens our hematology story, particularly when partnered with Vetscan Imagyst® AI Blood Smear – reinforcing the existing capabilities of Zoetis’ Virtual Laboratory portfolio, providing a comprehensive and connected platform.”
Dr. Richard Goldstein, DVM, DACVIM, DECVIM-CA, Global Chief Medical Officer and Head of Medical Affairs at Zoetis shared: “Vetscan OptiCell delivers high-quality results, enables improved efficiency, and provides a compact footprint. For the first time, we are able to use advanced AI image recognition technology to characterize the blood cells instead of relying on their size or other physical parameters. This is an important step forward for our hematology story, demonstrating Zoetis’ devotion to the well-being of animals and those that care for them.”
The innovative cartridge-based solution joins Vetscan® HM5 as the second Zoetis Diagnostics hematology analyzer available to customers, further expanding the in-clinic capability to count and characterize blood cells. Combined with the pioneering AI-powered Vetscan Imagyst analyzer, the state-of-the-art suite of products and services characterizes the future of veterinary diagnostics.
The first public viewing of the new analyzer will be at the internationally attended London Vet Show, booth N50, ExCel London, UK, 14-15 November 2024. Pre-orders will be available for customers in the US in late 2024.The analyzer will also be presented to North American customers at VMX in Orlando, January 2025.
Supported by the Virtual Laboratory’s integrated network of board-certified specialists, this portfolio provides world-leading pathology expertise at the fingertips of veterinarians and delivers deep insights to elevate patient care.